Get the Stockscreener App
5.48
3.20%
0.17
After Hours:
5.48
Agenus Inc stock is traded at $5.48, with a volume of 626.82K.
It is up +3.20% in the last 24 hours and up +6.41% over the past month.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
See More
Previous Close:
$5.31
Open:
$5.31
24h Volume:
626.82K
Relative Volume:
0.90
Market Cap:
$118.43M
Revenue:
$156.31M
Net Income/Loss:
$-245.76M
P/E Ratio:
-6.4471
EPS:
-0.85
Net Cash Flow:
$-234.16M
1W Performance:
+3.40%
1M Performance:
+6.41%
6M Performance:
-52.76%
1Y Performance:
-75.75%
1-Day Range:
$5.31
$5.81
1-Week Range:
$4.94
$5.81
52-Week Range:
$4.41
$23.20
Agenus Inc Stock (AGEN) Company Profile
Name
Agenus Inc
Sector
Industry
Phone
781-674-4410
Address
3 FORBES ROAD, LEXINGTON, MA
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-23 | Initiated | Robert W. Baird | Outperform |
| Feb-28-23 | Resumed | H.C. Wainwright | Buy |
| Sep-28-22 | Initiated | SMBC Nikko | Outperform |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Apr-22-19 | Initiated | B. Riley FBR | Buy |
| Oct-28-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-27-16 | Reiterated | Maxim Group | Buy |
| Mar-11-16 | Upgrade | Maxim Group | Hold → Buy |
| Dec-16-15 | Initiated | Jefferies | Buy |
| Oct-27-15 | Downgrade | Maxim Group | Buy → Hold |
| Jul-27-15 | Reiterated | MLV & Co | Buy |
| Jun-11-15 | Initiated | Oppenheimer | Outperform |
| Jan-12-15 | Reiterated | Maxim Group | Buy |
| Jan-09-15 | Reiterated | MLV & Co | Buy |
| Jan-09-15 | Reiterated | Maxim Group | Buy |
| Dec-19-14 | Reiterated | Maxim Group | Buy |
| May-08-14 | Reiterated | Maxim Group | Buy |
| Mar-14-14 | Reiterated | MLV & Co | Buy |
| Oct-08-13 | Reiterated | Maxim Group | Buy |
| Jan-05-12 | Initiated | William Blair | Outperform |
| Dec-01-11 | Initiated | Global Hunter Securities | Buy |
View All
Agenus Inc Stock (AGEN) Latest News
Agenus Inc. Class Action Reminder – AGEN Stockholders with Large Losses They Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Agenus Inc. Class Action Lawsuit - ForexTV.com
Agenus Inc. Class Action ReminderAGEN Stockholders with Large Losses They Should Contact Shareholder - Daily Guardian Canada
Shareholders that lost money on Agenus Inc.(AGEN) Urged to - GlobeNewswire
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN - GlobeNewswire Inc.
Renaissance Technologies LLC Reduces Holdings in Agenus Inc. (NASDAQ:AGEN) - MarketBeat
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - Markets Insider
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit - PR Newswire
AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
AGEN LAWSUIT ALERT: The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Lelezard
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - Marketscreener.com
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN - GlobeNewswire Inc.
Rhumbline Advisers Has $540,000 Stock Position in Agenus Inc. (NASDAQ:AGEN) - MarketBeat
AGEN LAWSUIT ALERT: The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - Kilgore News Herald
Lawsuit filed for Investors who lost money with shares of Agenus Inc. (NASDAQ: AGEN) - openPR
Shareholder Rights Law Firm Robbins LLP Reminds AGEN Stockholders with Large Losses They Should Obtain Counsel to Seek Lead Plaintiff Status in the Agenus Inc. Class Action Lawsuit - Business Wire
Shareholders that lost money on Agenus Inc. (AGEN) Urged to Join Class Action – Contact Levi & Korsinsky to - EIN News
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - PR Newswire
Agenus Inc (AGEN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
AGEN Investors Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – AGEN - GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - Markets Insider
Agenus Inc (AGEN) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Agenus Inc. (NASDAQ:AGEN) Shares Sold by Oracle Investment Management Inc. - MarketBeat
AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit - Kilgore News Herald
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Agenus - GlobeNewswire
Ratio Analysis: Unpacking Agenus Inc (AGEN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Agenus Inc (AGEN) did well last session? - US Post News
AGEN LAWSUIT ALERT: The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, New Fortress, and ZoomInfo and Encourages Investors to Contact the Firm - ForexTV.com
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit - Morningstar
Agenus stock plummets over 50% as FDA rejects accelerated approval for BOT/BAL cancer therapy - MSN
114,677 Shares in Agenus Inc. (NASDAQ:AGEN) Acquired by Federated Hermes Inc. - MarketBeat
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - AccessWire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 5, 2024 in Agenus Lawsuit - Longview News-Journal
AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit - ForexTV.com
AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit - GlobeNewswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN - ForexTV.com
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in - EIN News
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Bank of New York Mellon Corp Has $1.50 Million Position in Agenus Inc. (NASDAQ:AGEN) - MarketBeat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 5, 2024 in Agenus LawsuitAGEN - Morningstar
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - PR Newswire
Agenus Inc Stock (AGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):